Comparison between Fentanyl, Clonidine and Dexmedetomidine for Awake Fiberoptic Intubation
Abstract
Background: Currently Awake fibreoptic intubation - (AFOI) is the gold standard for the management of patients with an anticipated difficult airway. Various medications have been used to perform intubation during AFOI. The ideal drug for AFOI must provide comfort, cooperation, amnesia and hemodynamic stability along with maintenance of spontaneous respiration. The study aimed to compare fentanyl, clonidine and dexmedetomidine in providing favourable intubating conditions along with hemodynamic stability during AFOI.
Methods: This prospective and randomized trial was carried out in 90 patients who were scheduled for elective surgery and required awake fibreoptic intubation. The patients were randomly divided into three different groups; Group A: Received Injection Dexmedetomidine-1ug/kg over 10 minutes; Group B: Received Injection Clonidine -2ug/kg over 10 minutes; and Group C: Received Injection Fentanyl- 2ug/kg over 10 minutes. Cough score, post-intubation score, Ramsay sedation score (RSS) and the changes in hemodynamic, were used to evaluate the effectiveness of the intubation condition and the results were then compared among the groups.
Results: Demographic variables such as gender, age, weight and American Society of Anaesthesiologists-Physical Status ASA-PS (I/II) were comparable among the three groups and not statistically significant. The cough score and the post intubation score were lower in Group A. RSS was noted to be higher in Group A and there was a lower incidence of desaturation. Hemodynamic parameters were also favourable in Group A.
Conclusion: Dexmedetomidine was found to be more effective than clonidine and fentanyl in those undergoing awake fibreoptic intubation. There were fewer adverse effects such as coughing, discomfort, oxygen desaturation, and intolerance to intubation.
[2] Singh P, Punia TS, Kaur B, Ramachandriah P, Kaur J. A randomised comparative study of dexmedetomidine and midazolam for sedation during awake fiberoptic intubation in laparoscopic cholecystectomy patients. Int J Clin Trials. 2015; 2:1–9.
[3] Collins SR, Blank RS. Fiberoptic intubation: An overview and update. Respir Care. 2014; 59:865–78.
[4] Lallo A, Billard V, Bourgain JL. A comparison of propofol and remifentanil target-controlled infusions to facilitate fiberoptic nasotracheal intubation. Anesth Analg. 2009; 108:852-7.
[5] Rai MR, Parry TM, Dombrovskis A, Warner OJ. Remifentanil target-controlled infusion vs propofol target-controlled infusion for conscious sedation for awake fibreoptic intubation: A double-blinded randomized controlled trial. Br J Anaesth 2008; 100:125-30.
[6] Bailey PL, Pace NL, Ashburn MA, Moll JW, East KA, Stanley TH. Frequent hypoxemia and apnea after sedation with midazolam and fentanyl. Anesthesiology. 1990; 73:826-30.
[7] Struys MM, Vanluchene AL, Gibiansky E, Gibiansky L, Vornov J, Mortier EP, et al. AQUAVAN injection, a water-soluble prodrug of propofol, as a bolus injection: A phase I dose-escalation comparison with DIPRIVAN (part 2): Pharmacodynamics and safety. Anesthesiology 2005; 103:730-43.
[8] Johnston KD, Rai MR. Conscious sedation for awake fibreoptic intubation: A review of the literature. Can J Anaesth. 2013; 60:584–99.
[9] Khan ZP, Ferguson CN, Jones RM. Alpha-2 and imidazoline receptor agonists. Their pharmacology and therapeutic role. Anaesthesia. 1999; 54:146–65.
[10] American Society of Anesthesiologists Task Force on Management of the Difficult Airway. Practice guidelines for management of the difficult airway: An updated report by the American Society of Anesthesiologists Task Force on Management of the Difficult Airway. Anesthesiology. 2003; 98:1269-77.
[11] Wang SY, Mei Y, Sheng H, Li Y, Han R, Quan CX, et al. Tramadol combined with fentanyl in awake endotracheal intubation. J Thorac Dis. 2013; 5:270-7.
[12] Dhasmana S, Singh V, Pal US. Awake blind nasotracheal intubation in temporomandibular joint ankylosis patients under conscious sedation using fentanyl and midazolam. J Maxillofac Oral Surg. 2010; 9:377-81
[13] Hall JE, Uhrich TD, Barney JA, Arain SR, Ebert TJ. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg. 2000; 90:699-705.
[14] Chu KS, Wang FY, Hsu HT, Lu IC, Wang HM, Tsai CJ. The effectiveness of dexmedetomidine infusion for sedating oral cancer patients undergoing awake fibreoptic nasal intubation. Eur J Anaesthesiol. 2010; 27(1):36-40.
[15] Bergese SD, Patrick Bender S, McSweeney TD, Fernandez S, Dzwonczyk R, Sage K. A comparative study of dexmedetomidine with midazolam and midazolam alone for sedation during elective awake fiberoptic intubation. J Clin Anesth. 2010; 22:35-40.
[16] Ryu JH, Lee SW, Lee JH, Lee EH, Do SH, Kim CS. Randomized double-blind study of remifentanil and dexmedetomidine for flexible bronchoscopy. Br J Anaesth. 2012; 108:503-11.
[17] Yavascaoglu B, Kaya FN, Baykara M, Bozkurt M, Korkmaz S. A comparison of esmolol and dexmedetomidine for attenuation of intraocular pressure and haemodynamic responses to laryngoscopy and tracheal intubation. Eur J Anaesthesiol. 2008; 25:517-9.
[18] Sonsale AR, Kale J. To evaluate the efficacy of dexmedetomidine infusion versus fentanyl infusion for sedation during awake fibreoptic intubation (AFOI). Indian Journal of Clinical Anaesthesia. 2020; 7(2):233-7.
[19] Soliman AHF, Mohamad R, Nasr IA. Awake fiberoptic intubation AFOI in anticipated difficult airway management: dexmedetomidine versus propofol-fentanyl combination. AinShams J Anesthesiol. 2013; 6:23–9.
| Files | ||
| Issue | Vol 10 No Supp. 1 (2024): Supplement 1 |
|
| Section | Research Article(s) | |
| Keywords | ||
| Dexmedetomidine clonidine fentanyl fibreoptic | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
